With a diverse range of external collaborations, a vaible upfrotn capatal access and start-up experienced team, Enspire Bio, Inc. is a drug discovery company addressing the task of filling the gap between basic research and translational development. Having a high concentration of cellular energetics, metabolism, and mitochondrial expertise, the firm's platform is enabled by the collaborative effort between key players in the metabolism field and entrepreneurs to transform drug research and development into a robust therapeutic pipeline. The firm is described as currently developing therapeutic programs for fatty liver disease, diabetes and obesity, epilepsy, Parkinsonâs, and diseases associated with mitophagy and lysosomal dysfunction
